Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

Podcast 2022004
Download attendance certificate
e-ESO podcast channel
Listen on Spotify
Listen on Apple
Listen on Google

Questions:

  1. How do you recommend performing the gross examination of the surgical specimen after neoadjuvant treatment?
  2. What about re-testing of tumor biomarkers on the residual tumor?
  3. How do you assess sentinel lymph nodes after neoadjuvant treatment?
  4. Would you summarize the tumor staging after neoadjuvant treatment?
Expert
Nicola Fusco'
Nicola Fusco
Associate Professor of Pathology Department of Oncology and Hemato-Oncology University of Milan
University of Milan and IRCCS European Institute of Oncology
Milan, Italy
03
Feb 2022
Download attendance certificate
e-ESO podcast channel
Listen on Spotify
Listen on Apple
Listen on Google
Related e-Sessions:
ESCO logo
ESCO is the College of the European School of Oncology for ESO students offering a structured educational pathway to enhance their oncology careers.
Ulm university
Ulm university
The e-ESO e-Sessions are part of the Master-Online Study Program Advanced Oncology of Ulm University
www.uni-ulm.de
The mastermind winners of
e-Session 660
  1. Reda Mohamed Husseen
  2. Marina Puchinskaya
  3. Zacharoula Sidiropoulou
ESO & OncoAlert
e-Eso Onco alert
Oncology education together via social media
facebook eso twitter eso instagram eso